40% bonus is extended for 3 days. Current stage of work. About bonuses.

Synthesit
2 min readMar 1, 2019

--

At the present stage of work, we are conducting a test check of various mechanical circuits in our cold transmutation reactor.

In the last release, we reported about the first stage of monetization of the Synthestech project.

The valuable elements obtained in the process of Cold transmutation are biologically active according to the canons of Chinese ancient medicine. We hope that they will be launched in the fall this year.

We are being asked questions about the scaling of production.

The first stage of monetization does not cancel our plans to further scale production to a significant scale, to the level of a global enterprise. Medicine and health do not limit the scope of technology. Although the results in medicine promise to be just phenomenal. Nevertheless, we will choose the most effective application of technology in terms of scaling. At the moment we are preparing only an experimental production.

Bonuses

We would like to inform you that we are considering the possibility to make our investors significant additional bonus when the sales volume reaches some at the first stage of monetization. We assume that the amount of bonus accruals on 1 purchased STT token will be greater than the income on other operations. Although we still have a lot to do, we have every reason for confident optimism.

#Synthestech

40% bonus is extended

You can buy project tokens on the link below: https://my.synthestech.com
Discounts are available temporary!

PS: We plan to make a video stream, preliminary on 16th of february. Details about time will be provided later.

Learn more and sign up for newsletter at our web site
ico.synthestech.com

--

--

Synthesit

Synthesit is the mineral with a broad-spectrum action that works as a biocatalyst for vital body functions. Learn more at www.synthesit.ee